Skip to main content

Stonepine Capital Management, LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1440771 BEND, OR

Position in HRTX

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$211,038
-$910,714 QoQ
Shares Held
490,787
-65.0% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#30
of 161 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Derivatives in HRTX

reported options exposure · as of Jun 30, 2026
CallValue
$430,000
CallShares
1,000,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $108,574,607 across 61 Biotechnology names. HRTX ranks #52 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $430,000 1,000,000
2026-06-30 $211,038 490,787
2026-03-31 $1,121,752 1,402,191
2026-03-31 $800,000 1,000,000
2025-12-31 $1,609,142 1,237,802
2025-09-30 $1,071,126 850,100
2025-06-30 $1,360,776 657,380
2025-03-31 $1,751,420 796,100
2024-12-31 $1,071,000 700,000